Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Smoldering Multiple Myeloma × daratumumab × Clear all

Phase

Status

Active not recruiting 2 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 14 Triple Negative Breast Neoplasms 1 Smoldering Multiple Myeloma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Paraproteinemias 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Immunoglobulin Light-chain Amyloidosis 1 Hematologic Diseases 1 Hemangioma, Cavernous, Central Nervous System 1 Corneal Diseases 1 Blood Protein Disorders 1

Interventions

daratumumab 1 Dietary Fiber 1 Diet, Mediterranean 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07393282 2026-03-16

LINKER-SMM2

Regeneron Pharmaceuticals

Phase 3 Not yet recruiting

Smoldering Multiple Myeloma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡